{"filings":[{"id":98414,"accession_number":"0001193125-26-162667","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2026-04-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Neogen completes operational qualifications for Petrifilm SKUs; moves to performance qualifications","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Successfully completed multiple operational qualifications for certain Petrifilm single kit units (SKUs).","Proceeding forward on multiple performance qualifications for these SKUs as part of overall validation efforts.","Information disclosed during investor tours of Petrifilm manufacturing facility in Lansing, MI on April 20-21, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98413,"accession_number":"0001193125-26-148851","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2026-04-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Neogen Q3 FY26 revenue $211.2M; net loss $17M; divests Genomics unit","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $211.2M; Food Safety core growth +4.0%, Animal Safety core growth –8.7% on supplier challenges.","GAAP net loss $17.0M ($0.08 loss per share); Adjusted EPS $0.09; Adjusted EBITDA $48.2M (22.8% margin).","Divestiture of Genomics business announced, expected to close in Q2 FY27; proceeds to reduce leverage.","Raising FY2026 revenue outlook; maintaining Adjusted EBITDA guidance.","Petrifilm manufacturing transition on track for November FY27; validation on multiple SKUs started."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":645100000.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113864,"accession_number":"0001193125-26-130470","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2026-03-30T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Neogen's Chief Legal and Administrative Officer Amy Rocklin to depart March 31, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Amy Rocklin, Chief Legal and Administrative Officer, is leaving Neogen effective March 31, 2026.","No replacement or reason for departure was disclosed in the filing.","Departure follows a planned executive transition; no other officer changes announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113863,"accession_number":"0001193125-26-006990","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2026-01-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Neogen Q2 revenue $224.7M (-2.8% YoY); core growth +2.9%; raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $15.9M; adjusted net income of $22.6M; adjusted EBITDA of $48.7M.","Adjusted EBITDA margin improved 470 bps sequentially; Petrifilm transition on track.","Company hiring new senior commercial leaders; raising FY2026 revenue and adjusted EBITDA guidance.","Core growth of 2.9% YoY offset by foreign exchange and product mix headwinds."],"consensus_eps_estimate":null,"consensus_eps_actual":0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":433880000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130270,"accession_number":"0001193125-25-257565","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Neogen appoints Bryan Riggsbee as CFO effective Nov 3, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Riggsbee named SVP & CFO, succeeding David Naemura who remains through end of 2025 to aid transition.","He joins from bioMérieux where he was CFO of $2B North American business; previously CFO at Myriad Genetics.","Compensation: $600k base salary, 80% target bonus, $2M annual LTIP target, $2.25M sign-on equity, $250k sign-on cash.","Relocation to Michigan within 24 months; subject to non-compete and non-solicitation agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130267,"accession_number":"0001193125-25-252843","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K/A","filed_at":"2025-10-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Neogen assigns new director Avi Pelossof to Audit and Compensation Committees","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Avi Pelossof appointed to Audit Committee and Compensation and Talent Management Committees effective October 24, 2025.","Committee assignments were determined after the original board appointment announcement on August 14, 2025.","No other changes to director composition or compensatory arrangements are reported."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130269,"accession_number":"0001193125-25-250823","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-10-27T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Neogen shareholders reject say-on-pay at 2025 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Directors Thierry L. Bernard, Mikhael Nassif, Avi Pelossof, Andrea F. Wainer elected with >90% support.","Non-binding say-on-pay proposal failed: 167.1M for, 17.7M against, 412K abstain, 9.8M broker non-vote.","Ratification of BDO USA as auditor for FY2026 approved: 181.6M for, 13.1M against.","Meeting held Oct 23, 2025; 195M shares voted out of 217M outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.15,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130266,"accession_number":"0001193125-25-250963","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K/A","filed_at":"2025-10-27T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Neogen amends 8-K to show shareholders approved executive compensation proposal","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Original 8-K incorrectly reported Proposal 2 (say-on-pay) as not approved; corrected to show approval.","Say-on-pay vote: 167,126,873 for, 17,679,601 against, 412,667 abstain at Oct 23, 2025 annual meeting.","All four director nominees elected; BDO USA ratified as auditor for fiscal year ending May 31, 2026.","Total shares voted: 195,086,461 of 217,298,626 outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.15,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130268,"accession_number":"0001193125-25-235081","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-10-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Neogen Q1 FY2026 revenue $209.2M, net income $36.3M; new CEO Mike Nassif","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $209.2M, net income $36.3M; adjusted net income $9.4M, adjusted EBITDA $35.5M.","Completed divestiture of Cleaners & Disinfectants business and repaid $100M debt.","Welcomed Mike Nassif as CEO and President effective August 11, 2025.","Restructuring actions taken at end of September to right-size cost base.","Reaffirming full-year outlook."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":209189000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146844,"accession_number":"0001193125-25-203554","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-09-15T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Neogen CFO & COO David Naemura resigns voluntarily; successor search underway","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Naemura will remain CFO/COO until October filing of 10-Q, no later than Dec 31, 2025.","Transition agreement: if employed through Dec 31, 2025, he receives 50% of annual target cash bonus.","Jim Walter, VP Global Operations, assumes oversight of Global Procurement, reports to CEO.","Bill Waelke, VP Investor Relations & Treasury, will handle finance questions during transition.","Company has engaged a leading executive search firm; no CFO replacement named yet."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146843,"accession_number":"0000950170-25-110547","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-08-21T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Neogen grants PSUs and stock options to CEO and other NEOs for FY2026 LTI","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Mikhael Nassif receives 414,365 PSUs (target) and 1,065,042 options at $5.43 strike, vesting over 3 years.","PSUs based on 3-year performance: Revenue CAGR (40%), Adjusted EBITDA Margin expansion (30%), Cash Flow Conversion (30%).","PSUs include rTSR modifier: +20% at 75th percentile, -20% below 25th percentile; max payout 200% of target.","CFO/COO David Naemura gets 230,203 PSUs and 591,690 options; CLCO Amy Rocklin gets 119,705 PSUs and 307,680 options.","Options have 10-year term, strike price $5.43; PSUs represent 50% of each NEO's FY2026 long-term incentive."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146842,"accession_number":"0000950170-25-108900","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-08-14T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Neogen announces board retirement of William Boehm, appointment of Avi Pelossof effective Oct 23/24","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William T. Boehm to retire from Neogen's Board effective Oct 23, 2025; served since 2011, chairs Audit Committee, member of Compensation & Talent Management Committee.","Avi Pelossof appointed to Board effective Oct 24, 2025 as Class II director; over 25 yrs in diagnostics market, most recently CEO of Immucor.","Pelossof previously Global President, Infectious Disease at Alere Inc., building a $750M portfolio and launching FDA CLIA-waived point-of-care test (now Abbott's ID NOW).","Pelossof will participate in Neogen's non-employee director compensation program as described in 2024 proxy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146841,"accession_number":"0000950170-25-099379","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-07-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Neogen Q4 FY2025 revenue $225.5M; net loss $612.2M on goodwill impairment; adj. EPS $0.05","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $225.5M; net loss $612.2M ($2.82 diluted loss) primarily from non-cash goodwill impairment.","Adjusted net income $11.3M ($0.05 diluted); adjusted EBITDA $40.6M.","Non-cash goodwill impairment of approximately $612M recognized in Q4."],"consensus_eps_estimate":null,"consensus_eps_actual":-5.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":894661000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146840,"accession_number":"0000950170-25-098159","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-07-24T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Neogen appoints Mikhael Nassif as President and CEO effective August 11, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mikhael Nassif, former Siemens Healthineers Global President of Point-of-Care Diagnostics, appointed CEO.","Effective August 11, 2025; base salary $800K, target bonus 100% of base, LTIP target $4.5M annually.","One-time sign-on equity of $2M (50% options, 50% RSUs) with four-year ratable vesting.","Sign-on cash award of $500K payable by Sept 5, 2025, subject to one-year repayment.","Relocation to Michigan within 24 months; company-provided apartment for first 24 months."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165277,"accession_number":"0000950170-25-081407","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-06-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Neogen furnishes investor presentation at William Blair conference; no specifics in filing","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Neogen presented at the William Blair Growth Stock Conference on June 4, 2025.","Presentation materials were furnished as Exhibit 99.1 to the 8-K.","The filing does not include detailed financial data or new guidance.","Investors are directed to the presentation for any forward-looking statements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165276,"accession_number":"0000950170-25-071169","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-05-14T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Neogen furnishes slides for BofA Healthcare Conference; no material new data provided","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Presentation at 2025 Bank of America Healthcare Conference on May 14.","Investor slides furnished under Regulation FD; content was not otherwise disclosed.","No financial results, guidance changes, or material events announced.","Filing does not contain specific revenue, EPS, or operational updates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165275,"accession_number":"0000950170-25-070353","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Neogen announces board retirement of James P. Tobin, appoints Andrea Wainer effective June 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["James P. Tobin retires from Neogen board effective May 31, 2025 after nine years of service.","Andrea Wainer appointed to board effective June 1, 2025; will serve on Governance and Sustainability and Science, Technology, and Innovation Committees.","Wainer brings 25+ years in diagnostics; most recently EVP Rapid and Molecular Diagnostics at Abbott Laboratories.","James C. Borel serves as interim chair of Governance and Sustainability Committee until successor appointed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165274,"accession_number":"0000950170-25-056821","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-04-22T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Neogen hosts investor meeting on Petrifilm product line","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Investor event held April 22, 2025, in Lansing, MI, focused on Petrifilm.","Presentation provided to attendees; no specific financial or performance metrics disclosed in the filing.","Petrifilm is Neogen's rapid microbial testing platform for food safety.","Ticker: NEOG; listed on Nasdaq Global Select Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165273,"accession_number":"0000950170-25-052304","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-04-09T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Neogen CEO John Adent to step down; board forms search committee","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Adent will remain CEO/President until successor appointed; then serve as Special Advisor through Oct 31, 2025.","Transition agreement provides base salary, 2025 annual bonus, and pro-rata 2026 bonus; no new equity grants.","Special committee (Jim Borel, Thierry Bernard, Jeff Capello) leading CEO search with global executive search firm.","Outstanding equity awards treated per terms; vested stock options exercisable for 3 years post-separation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165272,"accession_number":"0000950170-25-052302","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-04-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Neogen Q3 FY2025: revenue $221M, net loss $11M; updates guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $11.0M ($0.05 diluted EPS); adjusted net income of $20.9M ($0.10 adjusted EPS).","Revenue of $221.0M; adjusted EBITDA of $48.5M.","Full-year fiscal 2025 guidance updated in the press release."],"consensus_eps_estimate":0.0204,"consensus_eps_actual":-2.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":669202000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165271,"accession_number":"0000950170-25-051441","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-04-07T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"Neogen refinances $550M debt: new $450M term loan and $250M revolver at lower rate","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Refinanced $550M of existing term loan and revolver due 2027; new $450M term loan and $250M revolver mature Apr 2030.","Revolving facility upsized from $150M to $250M; initial $100M drawn; leverage-neutral transaction.","New interest rate: SOFR + 175 bps, 60 bps savings versus prior terms.","JPMorgan Chase acted as Administrative Agent and Joint Lead Arranger with four other banks."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182943,"accession_number":"0000950170-25-003775","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-01-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Neogen Q2 net loss $456.3M ($2.10/share) on goodwill impairment; adj EPS $0.11","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $231.3M; net loss $456.3M ($2.10 diluted) primarily from non-cash goodwill impairment.","Adjusted net income $24.4M; adjusted EPS $0.11; adjusted EBITDA $51.4M.","Company updating full-year fiscal 2025 guidance; specific changes not disclosed."],"consensus_eps_estimate":0.0765,"consensus_eps_actual":-2.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":448222000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182942,"accession_number":"0000950170-25-002820","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2025-01-07T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Neogen appoints David Naemura as COO alongside CFO; Doug Jones retiring Feb 28, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["David Naemura appointed COO effective Jan 1, 2025, retaining CFO role.","Compensation increased: base salary $650K, 100% annual bonus target, $2.5M LTI equity.","Doug Jones to retire as COO Feb 28, 2025; will stay part-time at $250/hr (min 40 hrs/month) through Dec 2025.","Company to create new Chief Commercial Officer role to lead global sales, marketing, and communications."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199526,"accession_number":"0000950170-24-137170","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K/A","filed_at":"2024-12-17T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Neogen adds committee assignments for director Thierry Bernard","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Amends prior 8-K to disclose committee roles for newly appointed director Thierry Bernard.","Bernard appointed to Governance and Sustainability and Compensation and Talent Management Committees.","Effective date of board appointment remains November 1, 2024.","No other changes to board composition or terms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199531,"accession_number":"0000950170-24-133084","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2024-12-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Neogen posts investor presentation for Piper Sandler Healthcare Conference","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Neogen filed an 8-K on December 4, 2024, regarding its presentation at the 2024 Piper Sandler Healthcare Conference.","The presentation materials were furnished as Exhibit 99.1 to the Form 8-K and are incorporated by reference.","The disclosure was made under Item 7.01 Regulation FD and Item 9.01 for exhibits.","The conference event took place on December 4, 2024, and the filing was signed by Chief Legal & Compliance Officer Amy M. Rocklin."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199530,"accession_number":"0000950170-24-117710","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2024-10-28T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Neogen shareholders reject say-on-pay at 2024 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Say-on-pay vote failed: 96,518,858 for vs. 101,431,438 against, 677,525 abstain.","Directors elected: Borel with 182,880,338 for, 15,916,347 withheld; Green with 172,216,006 for, 26,580,679 withheld.","Auditor BDO USA ratified with 204,919,449 votes for, 319,094 against.","205,366,298 of 216,698,138 shares outstanding were represented at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.15,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199529,"accession_number":"0000950170-24-113951","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2024-10-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Neogen COO Douglas E. Jones to retire early 2025; commercial role added","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["COO Douglas E. Jones plans retirement in early 2025; will facilitate transition of duties.","Operations organization will now report to CFO David H. Naemura.","Neogen adding an executive Chief Commercial Officer to lead global sales, marketing, and communications.","Jones will lead commercial organization until CCO is hired and oversee transition of function."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199528,"accession_number":"0000950170-24-113950","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2024-10-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Neogen Q1 net loss $12.6M; revenue down 5.3% YoY; guidance unchanged","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $217.0M, down 5.3% YoY; core revenue declined 1.4%; currency headwind 3.9%.","Net loss $(12.6)M ($(0.06) diluted EPS); Adjusted net income $14.4M ($0.07).","Adjusted EBITDA $43.7M (20.1% margin), down from $52.4M (22.9%) prior year.","Food Safety segment revenue $159.3M (-4.2% YoY) with 1.1% core growth; Animal Safety $57.6M (-8.1% YoY).","FY2025 outlook reaffirmed: revenue $925M-$955M, Adjusted EBITDA $215M-$235M, capex ~$85M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":216964000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199527,"accession_number":"0000950170-24-110564","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2024-10-01T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Neogen appoints QIAGEN CEO Thierry Bernard to board of directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Thierry Bernard appointed to Neogen Board of Directors, effective November 1, 2024.","Bernard is CEO of QIAGEN N.V. (NYSE: QGEN), a global molecular insights provider.","Bernard previously held senior roles at bioMérieux SA over 15 years.","Board determined Bernard qualifies as independent under Nasdaq listing standards.","Board Chair Jim Borel highlighted Bernard's science and technology expertise."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215571,"accession_number":"0000950170-24-103737","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2024-09-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Neogen furnishes investor presentation for Wells Fargo Healthcare Conference","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Presentation dated September 5, 2024, published for the 2024 Wells Fargo Healthcare Conference.","No specific financial results, guidance, or material operational updates provided in the filing.","Exhibit 99.1 content limited to a title slide and disclaimer; full presentation details not disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215570,"accession_number":"0000950170-24-087499","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2024-07-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Neogen Q4 revenue $236.8M down 2.1% YoY; net loss $0.02 EPS; guides FY25 rev $925-955M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $236.8M, down 2.1% YoY; core revenue grew 2.0% as FX headwind of 4.2% offset.","GAAP net loss $5.4M ($0.02 diluted); adjusted net income $22.4M ($0.10) vs $30.2M ($0.14) prior year.","Adjusted EBITDA $53.0M (22.4% margin) vs $63.1M (26.1%) prior year; gross margin fell to 47.9% from 50.9%.","Food Safety segment revenue $166.9M (-1.4% total, +4.3% core); Animal Safety $69.9M (-3.7% total, -3.3% core).","FY2025 guidance: revenue $925M-$955M (core mid-single-digit), Adj. EBITDA $215M-$235M, capex ~$85M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":924222000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234912,"accession_number":"0000950170-24-068311","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2024-06-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Neogen furnishes investor presentation for William Blair Growth Stock Conference","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Presentation materials published on June 4, 2024 for William Blair Growth Stock Conference.","Exhibit 99.1 contains the presentation, but no specific financial data was disclosed in the filing.","No material new information beyond the presentation availability; typical conference materials."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234911,"accession_number":"0000950170-24-042786","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2024-04-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Neogen reports Q3 revenue up 4.8% to $228.8M but net loss of $2.0M; cuts FY2024 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $2.0M ($0.01 diluted EPS) vs net income $8.2M ($0.04) a year ago.","Adjusted Net Income $26.4M ($0.12 diluted EPS), flat YoY; Adjusted EBITDA $52.7M (23.0% margin).","Cuts FY2024 revenue guidance to $910-920M and Adj. EBITDA to $210-215M.","Integration of 3M Food Safety creates operational inefficiencies slowing order fulfillment rates.","Cash and investments $168.4M; total debt $900.0M with $150M undrawn credit."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":687428000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234910,"accession_number":"0000950170-24-042096","cik":711377,"company_name":"NEOGEN CORP","ticker":"NEOG","form_type":"8-K","filed_at":"2024-04-05T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Neogen appoints John Moylan as VP, Corporate Controller and CAO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Moylan appointed VP, Corporate Controller, and Chief Accounting Officer effective April 15, 2024.","Moylan replaces David Naemura as principal accounting officer; Naemura remains CFO.","Base salary $350,000; target annual bonus 50% of base; one-time equity award $335,000 (options/RSUs).","Starting FY25 annual equity target of $200,000 (options/RSUs); severance includes salary and bonus.","Moylan previously served as VP, Corporate Controller and CAO at Covetrus; also held roles at BDO, GM, and PwC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2002592134.4857764,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}